去势水平睾酮导致雄激素敏感性会阴肌肉萎缩:男性性腺功能减退的潜在生物标志物
研究纳入38例中高危局限性前列腺癌患者,在雄激素剥夺治疗(ADT)前后行前列腺MRI,测量球海绵体肌(BCM)、坐海绵体肌(ICM)和肛提肌(LAM)宽度。ADT后双侧BCM/ICM/LAM宽度由7.16mm/7.95mm/5.53mm降至5.68mm/6.71mm/4.89mm(P<.001),睾酮下降预测会阴联合肌肉(BCM+ICM)宽度减少(P=.032)。作者认为该客观生物标志物可能有助于识别可能从睾酮替代中获益的患者。
要点
- ADT后双侧BCM/ICM/LAM宽度由7.16mm/7.95mm/5.53mm降至5.68mm/6.71mm/4.89mm(P<.001)。
- 基线睾酮286.5ng/dL,36/38例ADT后睾酮<50ng/dL。
- 睾酮下降预测会阴联合肌肉(BCM+ICM)宽度减少(P=.032)。
核心结论
- 雄激素剥夺导致BCM/ICM/LAM厚度显著且相对快速下降,该低睾酮状态的客观生物标志物可能有助于识别可能从睾酮替代中获益的患者。
研究设计与样本
- 前瞻性收集参加一项II期试验(NCT02430480)的中高危局限性前列腺癌患者数据,患者在前列腺切除术前接受ADT并在ADT前后行前列腺MRI。
- 采用T2W-MRI测量BCM、ICM和LAM,配对t检验评估宽度变化,线性回归分析评估睾酮变化与肌肉宽度变化的关系。
- 共分析38例连续有ADT前后MRI的患者。
主要发现
- 基线睾酮为286.5ng/dL,36/38例患者ADT后睾酮<50ng/dL。
- ADT前与ADT后双侧BCM/ICM/LAM宽度分别为7.16mm/7.95mm/5.53mm与5.68mm/6.71mm/4.89mm(P<.001)。
- 睾酮下降预测会阴联合肌肉(BCM+ICM)宽度减少(P=.032)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate MRI-based measurements of androgen-sensitive perineal/pelvic muscles in men with prostate cancer before and after androgen deprivation therapy (ADT) as a novel imaging marker for end-organ effects of hypogonadism. Diagnosing hypogonadism or testosterone deficiency (TD) requires both low serum testosterone and clinical symptoms, such as erectile dysfunction and reduced libido. However, the non-specific nature of many TD symptoms makes it challenging to initiate therapy. Objective markers of TD help to better identify patients who may benefit from testosterone supplementation; however, current markers, such as low bone mineral density, lack sensitivity. Previous studies suggest that decreased bulbocavernosus-muscle (BCM) thickness may be associated with TD, although it remains unclear if this is a correlative relationship. METHODS: Data were prospectively collected for patients with intermediate/high-risk localized prostate cancer enrolled in a phase II trial (NCT02430480). Patients received ADT before prostatectomy and underwent prostate MRI pre-/post-ADT. BCM, ischiocavernosus-muscle (ICM), and levator-ani-muscle (LAM) measurements were made using T2W-MRI. Paired t-tests evaluated changes in BCM/ICM/LAM width, and linear regression analyses evaluated relationships between changes in testosterone and muscle width. RESULTS: Thirty-eight consecutive patients with pre-/post-ADT MRIs were analyzed. Baseline testosterone was 286.5ng/dL, and 36/38 patients had post-ADT testosterone <50ng/dL. Pre-ADT and post-ADT measurements of the bilateral BCM/ICM/LAM width were 7.16mm/7.95mm/5.53mm and 5.68mm/6.71mm/4.89mm, respectively (P <.001). Decreases in testosterone predicted reduction in combined perineal muscle (BCM+ICM) width (P = .032). CONCLUSION: Androgen deprivation led to significant and relatively rapid decreases in BCM/ICM/LAM thickness. This objective biomarker of low testosterone states may help identify patients who will potentially benefit from testosterone replacement.
引用
- Rathi N, Blake Z, Hyman J, et al. Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism. Urology. 2024. PMID: 39427924. doi:10.1016/j.urology.2024.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。